Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Immunotherapies: exploiting the immune system for cancer treatment
J Koury, M Lucero, C Cato, L Chang… - Journal of …, 2018 - Wiley Online Library
Cancer is a condition that has plagued humanity for thousands of years, with the first
depictions dating back to ancient Egyptian times. However, not until recent decades have …
depictions dating back to ancient Egyptian times. However, not until recent decades have …
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance
JA McCubrey, LS Steelman, WH Chappell… - …, 2012 - pmc.ncbi.nlm.nih.gov
The Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades are often activated by genetic
alterations in upstream signaling molecules such as receptor tyrosine kinases (RTK) …
alterations in upstream signaling molecules such as receptor tyrosine kinases (RTK) …
Xanthohumol from Hop: Hope for cancer prevention and treatment
Cancer is a major public health concern due to high mortality and poor quality of life of
patients. Despite the availability of advanced therapeutic interventions, most treatment …
patients. Despite the availability of advanced therapeutic interventions, most treatment …
A pH-responsive yolk-like nanoplatform for tumor targeted dual-mode magnetic resonance imaging and chemotherapy
Incorporation of T1 and T2 contrast material in one nanosystem performing their respective
MR contrast role and simultaneously serving as an efficient drug delivery system (DDS) has …
MR contrast role and simultaneously serving as an efficient drug delivery system (DDS) has …
Protein kinase Cδ suppresses autophagy to induce kidney cell apoptosis in cisplatin nephrotoxicity
D Zhang, J Pan, X **ang, Y Liu, G Dong… - Journal of the …, 2017 - journals.lww.com
Nephrotoxicity is a major adverse effect in cisplatin chemotherapy, and renoprotective
approaches are unavailable. Recent work unveiled a critical role of protein kinase Cδ …
approaches are unavailable. Recent work unveiled a critical role of protein kinase Cδ …
DNA damage response in nephrotoxic and ischemic kidney injury
M Yan, C Tang, Z Ma, S Huang, Z Dong - Toxicology and Applied …, 2016 - Elsevier
DNA damage activates specific cell signaling cascades for DNA repair, cell cycle arrest,
senescence, and/or cell death. Recent studies have demonstrated DNA damage response …
senescence, and/or cell death. Recent studies have demonstrated DNA damage response …
Nanoparticle therapeutics: Technologies and methods for overcoming cancer
It is anticipated that by 2030 approximately 13 million people will die of cancer. Common
cancer therapy often fails due to the development of multidrug resistance (MDR), resulting in …
cancer therapy often fails due to the development of multidrug resistance (MDR), resulting in …
Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells
The organometallic “half-sandwich” compound [Os (η6-p-cymene)(4-(2-pyridylazo)-N, N-
dimethylaniline) I] PF6 is 49× more potent than the clinical drug cisplatin in the 809 cancer …
dimethylaniline) I] PF6 is 49× more potent than the clinical drug cisplatin in the 809 cancer …
A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN)
J Guan, Q Li, Y Zhang, N **ao, M Chen, Y Zhang… - …, 2016 - pmc.ncbi.nlm.nih.gov
Purpose This study was performed to compare the efficacies and toxicities of cisplatin
(CDDP)-and carboplatin (CBDCA)-based chemotherapy (CT) in patients with SCCHN …
(CDDP)-and carboplatin (CBDCA)-based chemotherapy (CT) in patients with SCCHN …
Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian …
Ovarian cancer is the fifth leading cause of cancer-related female deaths. Due to serious
side effects, relapse and resistance to standard chemotherapy, better and more targeted …
side effects, relapse and resistance to standard chemotherapy, better and more targeted …